Australia vs Jamaica: Adults (ages 15+) and children (0-14 years) living with HIV
Australia
31,000
in 2024
Jamaica
28,000
in 2024
Australia rank
71st
Jamaica rank
74th
Adults (ages 15+) and children (0-14 years) living with HIV over time
- Australia
- Jamaica
How they compare
Australia currently reports 31,000 against 28,000 in Jamaica, a difference of 3,000.
That makes Australia's figure about 1.1 times Jamaica's.
The two have swapped places 2 times across 35 shared years of data; in 1990 it was Australia ahead.
Australia ranks 71st and Jamaica ranks 74th of 152 countries.
Across the 4 decades both report, Australia averaged higher in 1 and Jamaica in 3.
Head to head by decade
| Decade | Australia | Jamaica | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 10,110 | 17,630 | 7,520 | Jamaica |
| 2000s | 15,600 | 29,400 | 13,800 | Jamaica |
| 2010s | 24,000 | 28,700 | 4,700 | Jamaica |
| 2020s | 29,800 | 28,000 | 1,800 | Australia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher adults (ages 15+) and children (0-14 years) living with hiv, Australia or Jamaica?
- Australia, at 31,000 against 28,000 in Jamaica as of 2024.
- What is the difference in adults (ages 15+) and children (0-14 years) living with hiv between Australia and Jamaica?
- 3,000, with Australia ahead.
- How many years of comparable data are there for Australia and Jamaica?
- 35 years are reported by both, from 1990 to 2024.
- How do Australia and Jamaica rank globally for adults (ages 15+) and children (0-14 years) living with hiv?
- Australia ranks 71st and Jamaica ranks 74th of 152 countries.
- Where does this data come from?
- UNAIDS estimates, published as Adults (ages 15+) and children (0-14 years) living with HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Adults and children living with HIV refers to the number of people ages 0-49 (adult ages 15-49 and children ages 0-14) who are infected with HIV.